Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Patients' Satisfaction with the ORCAM MyEye Device Among Visually Impaired People: A Multicenter Study.
Amore F, Silvestri V, Guidobaldi M, Sulfaro M, Piscopo P, Turco S, De Rossi F, Rellini E, Fortini S, Rizzo S, Perna F, Mastropasqua L, Bosch V, Oest-Shirai LR, Haddad MAO, Higashi AH, Sato RH, Pyatova Y, Daibert-Nido M, Markowitz SN. Amore F, et al. Among authors: mastropasqua l. J Med Syst. 2023 Jan 16;47(1):11. doi: 10.1007/s10916-023-01908-5. J Med Syst. 2023. PMID: 36645535
Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
Wong TY, Haskova Z, Asik K, Baumal CR, Csaky KG, Eter N, Ives JA, Jaffe GJ, Korobelnik JF, Lin H, Murata T, Ruamviboonsuk P, Schlottmann PG, Seres AI, Silverman D, Sun X, Tang Y, Wells JA, Yoon YH, Wykoff CC; YOSEMITE and RHINE Investigators. Wong TY, et al. Ophthalmology. 2024 Jun;131(6):708-723. doi: 10.1016/j.ophtha.2023.12.026. Epub 2023 Dec 28. Ophthalmology. 2024. PMID: 38158159 Free article. Clinical Trial.
Managing the ocular surface after glaucoma filtration surgery: an orphan topic.
Agnifili L, Figus M, Sacchi M, Oddone F, Villani E, Ferrari G, Posarelli C, Carnevale C, Nucci P, Nubile M, Mastropasqua L. Agnifili L, et al. Among authors: mastropasqua l. Graefes Arch Clin Exp Ophthalmol. 2023 Dec 13. doi: 10.1007/s00417-023-06333-5. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 38091058 Review.
A machine learning approach to predict the glaucoma filtration surgery outcome.
Agnifili L, Figus M, Porreca A, Brescia L, Sacchi M, Covello G, Posarelli C, Di Nicola M, Mastropasqua R, Nucci P, Mastropasqua L. Agnifili L, et al. Among authors: mastropasqua l. Sci Rep. 2023 Oct 24;13(1):18157. doi: 10.1038/s41598-023-44659-6. Sci Rep. 2023. PMID: 37875579 Free PMC article.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
A deep learning approach to investigate the filtration bleb functionality after glaucoma surgery: a preliminary study.
Mastropasqua L, Agnifili L, Brescia L, Figus M, Posarelli C, Oddone F, Giammaria S, Sacchi M, Pavan M, Innocenti DD, Olivotto V, Sensi SL, Mastropasqua R. Mastropasqua L, et al. Graefes Arch Clin Exp Ophthalmol. 2024 Jan;262(1):149-160. doi: 10.1007/s00417-023-06170-6. Epub 2023 Aug 2. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37530849 Free PMC article.
285 results